Functional cardiomyocytes from human embryonic stem cells
US7611852B2 · kind B2 · utility
4Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2003 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Apr 28, 2024 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5088
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Human embryonic stem cells form embryoid bodies in culture which contain differentiated human cells. Some of the human cells in embryoid bodies differentiate into cardiomyocytes. Here the biological and electrical characteristics of those cardiomyocytes are described with reference to the use of cardiomyocytes derived from human embryonic stem cells in drug screening protocols for mechanisms of cardiac toxicity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.